Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-18

Clinical Trial Update: SVT-15652 Otic Solution for the Treatment of Otomycosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SVT-15652 Otic Solution for otomycosis has completed, with results posted in January 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SVT-15652 Otic Solution

Snippet

Sponsor: Salvat | Conditions: Otomycosis | Phase 3 | Status: COMPLETED | Results posted: 2023-01-18